AFP and hepatocellular carcinoma: Additionally, we measured the serum levels of the protein induced by the absence of vitamin K or antagonist-II (PIVKA-II), a more sensitive circulating marker than AFP for differentiating HCC at all stages in patients with cirrhosis or chronic hepatitis.